Protic- or anionic-NHCs with a classical-NHC in a single [Ru(CNC)(PPh3)2Cl]Cl pincer complex: direct comparison of structure & electronic properties and heterolytic H2 splitting.

Herein, we report the first set of pincer complexes 1 and 2 with the general formula [Ru(CNC)(PPh3)2Cl]Cl having a protic- and classical-NHC in the same molecule and nearly identical environments. Deprotonation of the protic-NHC complex 2 with one equivalent of base leads to the formation of anionic-NHC complex 2'. These complexes allow a direct comparison of protic- and anionic-NHCs with the classical-NHC ligand. A comparison of the molecular structure indicated that the metal carbene bond length trend is anionic-NHC > protic-NHC > classical-NHC. The electrochemical investigation revealed the electron donation tendency is classical-NHC > protic-NHC and anionic-NHC > protic-NHC. Cooperation between the metal and the ligand is indicated by the reaction of 2' with H2 gas at 1 atm pressure and 110 °C to give the Ru-hydride complex 3.

Role of ancillary ligands in selectivity towards acceptorless dehydrogenation versus dehydrogenative coupling of alcohols and amines catalyzed by cationic ruthenium(II)-CNC pincer complexes.

An unexpected reversal in catalytic activity for acceptorless dehydrogenative coupling compared to acceptorless alcohol dehydrogenation has been observed using a series of cationic Ru(II)-CNC pincer complexes with different ancillary ligands. In continuation of our study of cationic Ru(II)-CNC pincer complexes 1a-6a, new complexes with bulky N-wingtips [Ru(CNCiPr)(CO)(PPh3)Br]PF6 (1b), [Ru(CNCCy)(CO)(PPh3)Cl]PF6 (1c), [Ru(CNCCy)(CO)(PPh3)H]PF6 (2c), [Ru(CNCiPr)(PPh3)2Cl]PF6 (3b), [Ru(CNCCy)(PPh3)2Cl]PF6 (3c), [Ru(CNCiPr)(PPh3)2H]PF6 (4b), [Ru(CNCCy)(PPh3)2H]PF6 (4c), [Ru(CNCiPr)(DMSO)2Cl]PF6 (6b), and [Ru(CNCCy)(DMSO)2Cl]PF6 (6c) [CNCR = 2,6-bis(1-alkylimidazol-2-ylidene)-pyridine] have been synthesized and the catalytic activities of the new complexes have been compared with their N-methyl analogues for transfer hydrogenation of cyclohexanone and acceptorless dehydrogenation of benzyl alcohol. Furthermore, all complexes have been utilized as catalysts in the dehydrogenative coupling reaction of benzyl alcohol with amines. While the catalytic activities of the new complexes for transfer hydrogenation and acceptorless alcohol dehydrogenation were found to be in line with the previously observed trend based on the ancillary ligands (CO > COD > DMSO > PPh3), for the acceptorless dehydrogenative coupling reaction, complexes containing PPh3 and DMSO ligands performed better compared to complexes containing CO and COD ligands. Based on NMR and mass investigation of catalytic reactions, a plausible mechanism has been suggested to explain the difference in catalytic activity and its reversal during the dehydrogenative coupling reaction. Furthermore, the substrate scope for the dehydrogenative coupling reaction of benzyl alcohol with a wide range of amines has been explored, including synthesizing some pharmaceutically important imines. All new complexes have been characterized by various spectroscopic techniques, and the structures of 4b and 6b have been confirmed by the single-crystal X-ray diffraction technique.

Case report on meningoenceplapathy in an Indian patient post CoViD vaccination.

The SARS-COV-2 infection-related severe illness is prevented by vaccinations. Therefore, it is relevant to report a case of post vaccine meningoencephalitis in a 30 year old male Indian patient, who presented with weakness in all the extremities, episodes of loose stool, fever, vomiting, tachypnea and loss of consciousness immediately following the 2nd dose of the COVID vaccination (COVAXIN).

Ru(II) Complexes with Protic- and Anionic-Naked-NHC Ligands for Cooperative Activation of Small Molecules.

A set of ruthenium(II)-protic-N-heterocyclic carbene complexes, [Ru(NNCH )(PPh3 )2 (X)]Cl (1, X=Cl and 2, X=H) and their deprotonated forms [Ru(NNC)(PPh3 )2 (X)] (1', X=Cl and 2', X=H), in which NNC is a new unsymmetrical pincer ligand, are reported. The four complexes are interconvertible by simple acid-base chemistry. The combined theoretical and spectroscopic investigations indicate charge segregation in anionic-NHC complexes (1' and 2') and can be described from a Lewis pair perspective. The chemical reactivity of deprotonated complex 1' shows cooperative small molecule activation. Complex 1' activates H-H bond of hydrogen, C(sp3 )-I bond of iodomethane, and C(sp)-H bond of phenylacetylene. The activation of CO2 using anionic NHC complex 1' at moderate temperature and ambient pressure and subsequent conversion to formate is also described. All the new compounds have been characterized using ESI-MS, 1 H, 13 C, and 31 P NMR spectroscopy. Molecular structures of 1, 2, and 2' have also been determined with single-crystal X-ray diffraction. The cooperative small molecule activation perspective broadens the scope of potential applications of anionic-NHC complexes in small molecule activation, including the conversion of carbon dioxide to formate, a much sought after reaction in the renewable energy and sustainable development domains.

Base-free synthesis of benchtop stable Ru(III)-NHC complexes from RuCl3·3H2O and their use as precursors for Ru(II)-NHC complexes.

A series of Ru(III)-NHC complexes, identified as [RuIII(PyNHCR)(Cl)3(H2O)] (1a-c), have been prepared, starting from RuCl3·3H2O following a base-free route. The Lewis acidic Ru(III) centre operates via a halide-assisted, electrophilic C-H activation for carbene generation. The best results were obtained with azolium salts having the I- anion, while ligand precursors with Cl-, BF4-, and PF6- gave no complex formation and those with Br- gave a product with mixed halides. The structurally simple, air and moisture-stable complexes represent rare examples of paramagnetic Ru(III)-NHC complexes. Furthermore, these benchtop stable Ru(III)-NHC complexes were shown to be excellent metal precursors for the synthesis of new [RuII(PyNHCR)(Cl)2(PPh3)2] (2a-c) and [RuII(PyNHCR)(CNCMe)I]PF6 (3a-c) complexes. All the complexes have been characterised using spectroscopic methods, and the structures of 1a, 1b, 2c, and 3a have been determined using the single-crystal X-ray diffraction technique. This work allows easy access to new Ru-NHC complexes for the study of new properties and novel applications.

Prevalence of medical comorbidity in early onset versus late-onset depression in Vindhya region.

BACKGROUND: Late-onset depression differs significantly from early-onset depression according to clinical features, physical comorbidities, cognitive impairment, and cerebrovascular abnormalities, which suggest that these might have differing etiopathological pathways toward the depressive phenotype. AIM: The aim of the study was to identify comorbid physical disorders with late-onset depression. METHODS: The present cross-sectional study was conducted in inpatients of the Department of Psychiatry during a period of 18 months. A study consisted of 60 patients of first depressive episode diagnosed using International Classification of Diseases-10 criteria, segregated 2 different groups of Early onset depression (between 40 and 65 years) and late-onset depression (LOD) (>65 years) with 30 patients each. RESULTS: In LOD group, predominant comorbidities were hypertension 56.6%, cerebrovascular disease 36.6%, diabetes 33.3%, cardiovascular disease 23.3%, and anaemia 23.3%, followed by respiratory illnesses, arthritis, benign prostatic hyperplasia and cirrhosis. While, in early-onset depression group, common comorbidities were hypertension (13.3%), anemia (10%), arthritis (10%), and diabetes (6.6%). CONCLUSIONS: Hypertension cerebrovascular disease, diabetes, and cardiovascular disease were the predominant comorbidities in late-onset as well as early onset depression.

Transformation of Battery to High Performance Pseudocapacitor by the Hybridization of W18O49 with RuO2 Nanostructures.

Defects such as oxygen vacancy in the nanostructures have paramount importance in tuning the optical and electronic properties of a metal oxide. Here we report the growth of oxygen deficit tungsten oxide (W18O49) nanorods modified with ruthenium oxide (RuO2) using a simple and economical hydrothermal approach for energy storage application. In this work, a novel approach of hybridizing the W18O49 nanostructure with RuO2 to control the electrochemical performance for energy storage applications has been proposed. The result displays that the hybridization of the nanostructures plays an important role in yielding high specific capacitance of the electrode material. Due to the augmentation of W18O49 and RuO2 nanostructures, the galvanostatic charging and discharging (GCD) mechanism exhibited the transformation from the battery type characteristics of W18O49 into the typical pseudocapacitor feature of hybrid architect nanostructure due to defect creations. The electrochemical measurement of hybrid nanomaterial shows the doubling of specific capacitance to 1126 F/g and 1050 F/g in cyclic voltammetry (CV) and GCD, respectively, in comparison with W18O49 and RuO2 and earlier reports. The enhancement in the stability performance up to 3000 cycles of hybrid is indebted to the stable nature of W18O49 and the high conductivity of RuO2.

Design and in vitro analysis of SIRT2 inhibitor targeting Parkinson's disease.

Inhibition of Sirtuin2 (SIRT2) protein rescues the α-synuclein toxicity in vitro and in vivo models of Parkinson's disease (PD). Thioacetyl group can structurally mimic the acetyl group and restrain the deacetylating p53 reaction by SIRT2. This work evaluated the biological activity of designed pentapeptides inhibitor containing N-thioacetyl-lysine against SIRT2. Pentapeptide by introducing thioacetyl-lysine as an inhibitor of SIRT2 was screened by molecular docking and synthesized by solid phase method. The inhibition of pure recombinant SIRT2 as well as SIRT2 in serum of PD patients by peptide was done by fluorescent activity assay. The inhibition of SIRT2 was assessed in PC12 cell line by measuring acetylated α-tubulin level. The peptide YKK(ε-thioAc)AM and HRK(ε-thioAc)AM were found to be SIRT2 inhibitors by molecular docking. However, YKK(ε-thioAc)AM was more specific towards SIRT2 than SIRT1 (Sirtuin1). It inhibited recombinant SIRT2 by IC50 value of 0.15 µM and KD values 9.92 × 10-8/M. It also inhibited serum SIRT2 of PD. It increased the acetylation of α-tubulin in PC12 neuroblastoma cells which is essential for maintaining the microtubular cell functions of brain. It can be concluded that novel peptide YKK(ε-thioAc)AM may be a platform for therapeutic agent for Parkinson's disease targeting SIRT2.

Atropine eye-drop-induced acute delirium: a case report.

Atropine is an anticholinergic drug which is used in both parental and topical routes. Topical eye-drops of atropine sulfate are used as mydriatic and cycloplegics. Parental atropine-induced delirium is well known but topical atropine eye-drop-induced delirium cases are very limited in literature. In this case report, an elderly man underwent cataract surgery and developed delirium after the use of 1% atropine sulfate eye-drops as prescribed. This case supports the notion that even atropine eye-drops can cause delirium in patients at therapeutic doses in elderly.

Asymmetric hydrogenation of an α-unsaturated carboxylic acid catalyzed by intact chiral transition metal carbonyl clusters - diastereomeric control of enantioselectivity.

Twenty clusters of the general formula [(µ-H)2Ru3(µ3-S)(CO)7(µ-P-P*)] (P-P* = chiral diphosphine of the ferrocene-based Walphos or Josiphos families) have been synthesised and characterised. The clusters have been tested as catalysts for asymmetric hydrogenation of tiglic acid [trans-2-methyl-2-butenoic acid]. The observed enantioselectivities and conversion rates strongly support catalysis by intact Ru3 clusters. A catalytic mechanism involving an active Ru3 catalyst generated by CO loss from [(µ-H)2Ru3(µ3-S)(CO)7(µ-P-P*)] has been investigated by DFT calculations.

Selective and Recyclable Congo Red Dye Adsorption by Spherical Fe3O4 Nanoparticles Functionalized with 1,2,4,5-Benzenetetracarboxylic Acid.

In this study, the new material Fe3O4@BTCA has been synthesized by immobilization of 1,2,4,5-Benzenetetracarboxylic acid (BTCA) on the surface of Fe3O4 NPs, obtained by co-precipitation of FeCl3.6H2O and FeCl2.4H2O in the basic conditions. Characterization by P-XRD, FE-SEM, and TEM confirm Fe3O4 has a spherical crystalline structure with an average diameter of 15 nm, which after functionalization with BTCA, increases to 20 nm. Functionalization also enhances the surface area and surface charge of the material, confirmed by BET and zeta potential analyses, respectively. The dye adsorption capacity of Fe3O4@BTCA has been investigated for three common dyes; Congo red (C.R), Methylene blue (M.B), and Crystal violet (C.V). The adsorption studies show that the material rapidly and selectively adsorbs C.R dye with very high adsorption capacity (630 mg/g), which is attributed to strong H-bonding ability of BTCA with C.R dye as indicated by adsorption mechanism study. The material also shows excellent recyclability without any considerable loss of adsorption capacity. Adsorption isotherm and kinetic studies suggest that the adsorption occurs by the Langmuir adsorption model following pseudo-second-order adsorption kinetics.

Electronic and Structural Comparisons between Iron(II/III) and Ruthenium(II/III) Imide Analogs.

To examine structural and electronic differences between iron and ruthenium imido complexes, a series of compounds was prepared with different phosphine basal sets. The starting material for the ruthenium complexes was Ru(NAr/Ar*)(PMe3)3 (Ru1/Ru1*), where Ar = 2,6-(iPr)2C6H3 and Ar* = 2,4,6-(iPr)3C6H2, which were prepared from cis-RuCl2(PMe3)4 and 2 equiv of LiNHAr/Ar*. The starting materials for the iron complexes were the analogous Fe(NAr/Ar*)(PMe3)3 species (Fe1/Fe1*), which were not isolated but could be generated in situ from FeCl2, PMe3, and LiNHAr/Ar*. With both iron and ruthenium, the PMe3 starting materials underwent phosphine replacement with chelating ligands to give new group 8 imido complexes in the +2 oxidation state. Addition of 1,2-bis(diphenylphosphino)ethane (dppe) to M1/M1* gave Ru(NAr/Ar*)(PMe3)(dppe) and Fe(NAr/Ar*)(PMe3)(dppe). Addition of 1,2-bis(dimethylphosphino)ethane (dmpe) provided Ru(NAr/Ar*)(dmpe)2. A triphos ligand, {P(Me)2CH2}3SitBu (tP3), was also examined. Addition of tP3 to Fe1 provided Fe(NAr)(tP3) (Fe4), but a similar reaction with Ru1 only gave intractable materials. Oxidation of Fe4 with AgSbF6 gave {Fe(NAr)(tP3)}+SbF6- (Fe4a). Oxidation of Ru2 with AgSbF6 gave the unstable cation {Ru(NAr)(PMe3)(dppe)}+, which dimerized in the presence of acetonitrile via C-C bond formation at the aryl group C4 positions, affording {Ru(NAr)(PMe3)(NCMe)(dppe)}2+. This suggested that there was substantial radical character in the imide π system on oxidation and that an aromatic group substituted at the 4-position might provide greater stability. The cations {Fe(NAr*)(PMe3)(dppe)}+ (Fe2a*), {Ru(NAr*)(PMe3)(dppe)}+ (Ru2a*), and Fe4a were examined by EPR spectroscopy, which suggested differences in electronic structure depending on the metal and ligand set. CASPT2 calculations on model systems for Ru2a* and Fe2a* suggested that the large differences in electronic structure are related to the energy gap between the π-antibonding HOMO and the π-bonding HOMO-1. Both the geometry of the phosphines, which is slightly different between the iron and ruthenium analogs, and the metal center seem to contribute to this energetic difference.

Elevated Serum SIRT 2 May Differentiate Parkinson's Disease From Atypical Parkinsonian Syndromes.

Atypical Parkinson syndromes (APSs) often have symptoms that overlap with those of Parkinson's disease (PD), especially early in the disease, making these disorders difficult to diagnose. Previous studies have demonstrated an association of oligomeric α-synuclein (α-Syn), a key element in the pathogenesis of PD, with Sirtuin (SIRT)2 proteins for modulating PD. We aimed to evaluate SIRT protein expression in serum of PD patients and compare it with APSs and normal elderly control (GC) and to correlate this with α-Syn. SIRT protein expression was evaluated in sera of 68 PD; 34 APS and 68 GC without any neuro-psychiatric illness as controls by surface plasmon resonance (SPR). SIRT2 expression was correlated with α-Syn in PD and GC. Significant (p < 0.0001) differences were observed between serum SIRT2 concentration in PD and APS and GC as well as between APS and GC. Receiver operating characteristic (ROC) analysis revealed the strong cut-off value to differentiate PD from APS and GC and also APS from GC. Significant correlation was observed among SIRT2 levels in early PD patients with Unified Parkinson's Disease Rating Scale (UPDRS), Hoehn & Yahr (H & Y) and increased duration of disease. In addition, a strong positive correlation of SIRT2 with α-Syn (p < 0.0001) was observed. However, no such difference was detected for serum SIRT1 in cases of PD and APS or for GC. The present study is the first to report elevated serum SIRT2 in PD. The study also provided a simple test to distinguish PD from APS and may have translational utility for diagnosis.

Concentrative (Sahaj Samadhi) meditation training and visual awareness: An fMRI study on color afterimages.

All of us consciously experience the world around us through our sensory modalities. Empirical studies on the relationship between attention and awareness have shown that attention does influence perceptual experience or appearance in addition to better performance in perceptual tasks. The practice of meditation also changes perceptual experience in addition to better perceptual performance. For example, a study with Sahaj Samadhi meditators utilizing negative color afterimages had shown that concentrative meditation influences visual experience. However the brain regions that are modified by meditation practice leading to such changes in visual experience or awareness are still not known. Here using negative color afterimages in a functional MRI study, we investigated the brain mechanisms underlying the changes in visual awareness as a function of attentional enhancement achieved through long-term concentrative meditation practice. We found increased activity in right lateralized inferior occipital and inferior frontal cortex, which suggests the importance of attentional control in modulating visual awareness. The results of this study indicate that the link between attention and conscious experience is possibly changed by meditation practices.

Concentrative (Sahaj Samadhi) meditation expands subjective time.

Previous studies have demonstrated the effect of mindfulness meditation on subjective experience of time. Task difficulty influenced subjective experience of time with larger subjective expansion of time among meditators with a more difficult task. It is not clear whether the effect would generalize to concentrative meditation training. Hence, in the present study, using a temporal bisection task, we investigated the effect of task difficulty (with two discrimination ratios of short and long durations) on subjective experience of time in long-term concentrative (Sahaj Samadhi) meditators and non-meditators. The results provide evidence for subjective expansion of time among long-term concentrative meditators, which is in line with the previous findings with mindfulness meditators. Similar to the earlier study with mindfulness meditators, we also found expansion of time for concentrative meditators only in the difficult task condition where attentional demands are high and less attentional resources are available for processing time. The findings suggest that subjective expansion of time is most likely a general effect of attentional enhancement irrespective of the type of meditation practice.

Neuroprotection by ethanolic extract of Syzygium aromaticum in Alzheimer's disease like pathology via maintaining oxidative balance through SIRT1 pathway.

The oxidative stress plays a key role in Alzheimer's disease (AD) and Sirtuin (SIRT1) is potential mediator of oxidative pathway. This study explored the role of Syzygium aromaticum on SIRT1 and oxidative balance in amyloid beta induced toxicity. Anti-oxidative capacity of Syzygium aromaticum was performed in Aß25-35 induced neurotoxicity in neuronal cells. Superoxide dismutase, Catalase and Glutathione enzyme activity were determined by the treatment of Syzygium aromaticum. Both recombinant and endogenous SIRT1 activity were performed in its presence. The expression of γ-secretase and SIRT1 were evaluated by western blot. Syzygium aromaticum was capable to scavenge ROS and elevate the percentage of anti-oxidant enzymes. It also activated and elevated the level of SIRT1 and downregulated γ-secretase level. These findings show a holistic approach towards the neurodegenerative disease management by Syzygium aromaticum which could lead to the formulation of new drug for AD. This Ayurvedic product can give a healthy aging with no side effects and also be cost effectives. It may meet unmet medical needs of current relevance.

The effect of sadness on global-local processing.

Gable and Harmon-Jones (Psychological Science, 21(2), 211-215, 2010) reported that sadness broadens attention in a global-local letter task. This finding provided the key test for their motivational intensity account, which states that the level of spatial processing is not determined by emotional valence, but by motivational intensity. However, their finding is at odds with several other studies, showing no effect, or even a narrowing effect of sadness on attention. This paper reports two attempts to replicate the broadening effect of sadness on attention. Both experiments used a global-local letter task, but differed in terms of emotion induction: Experiment 1 used the same pictures as Gable and Harmon-Jones, taken from the IAPS dataset; Experiment 2 used a sad video underlaid with sad music. Results showed a sadness-specific global advantage in the error rates, but not in the reaction times. The same null results were also found in a South-Asian sample in both experiments, showing that effects on global/local processing were not influenced by a culturally related processing bias.

Serum Mortalin Correlated with α-Synuclein as Serum Markers in Parkinson's Disease: A Pilot Study.

Mortalin, a mitochondrial chaperone, plays a crucial role in reducing toxicity of Lewy bodies. Earlier studies had reported that Mortalin level gets downregulated in astrocytes and other brain tissue samples in Parkinson's disease (PD). This study aims to estimate the Mortalin concentration in serum and correlate with α-synuclein (α-Syn) in PD. The concentration of Mortalin and α-Syn in serum samples of 38 PD patients and 33 control group (CG) individuals was quantified by surface plasmon resonance. The receiver operating characteristic curves were plotted to develop it as blood-based protein marker. The expression of Mortalin in serum was validated by western blot. The Mortalin level was found to be declined in PD patients (1.98 ± 0.53 ng/µL) in comparison with CG individuals (3.13 ± 0.48 ng/µL), whereas α-Syn level was found to be elevated in PD patients (38.20 ± 4.22 ng/µL) than CG individuals (34.31 ± 3.23 ng/µL) in serum. The statistical analysis revealed the negative correlation between Mortalin and α-Syn. This preliminary study summarized that Mortalin plays a significant role in PD with negative correlation with α-Syn. This study provides a new paradigm for the development of Mortalin as a potent serum protein marker for diagnosis of PD.

Design, synthesis of allosteric peptide activator for human SIRT1 and its biological evaluation in cellular model of Alzheimer's disease.

Sirtuin 1 (SIRT1) is one of the member of the mammalian proteins of the Sirtuin family of NAD+ dependent deacetylases, has recently been shown to attenuate amyloidogenic processing of amyloid protein precursor (APP) in in-vitro cell culture studies and transgenic mouse models of Alzheimer's disease (AD). SIRT1 has been shown to have a protective role against (AD). It has been reported earlier that increasing SIRT1 activity can prevent AD in mice model. Tripeptide as an activator of SIRT1 were screened on the basis of structural information by molecular docking and synthesized by solid phase method. The enhancement of biochemical activity of pure recombinant SIRT1 as well as SIRT1 in serum of AD patients in presence of tripeptide was done by Fluorescent Activity Assay. The activity of SIRT1 by peptide was assessed in IMR-32 cell line by measuring acetylated p53 level. Further the protective effect of SIRT1 activator in cellular model of AD was analyzed by MTT assay. We find CWR tripeptide as a SIRT1 activator by molecular docking, enhanced the activity of SIRT1 protein by lowering the Michaelis constant, Km by allosteric mechanism. The activity of serum SIRT1 of AD was also increases by CWR. It also decreased the acetylation of p53 in IMR32 neuroblastoma cells and protected the cell death caused by Aß amyloid fragments in cell line model of AD. Thus, it can be concluded that CWR may serve as platform to elucidate further small molecule activator as a therapeutic agent for AD targeting SIRT1.

A complex with nitrogen single, double, and triple bonds to the same chromium atom: synthesis, structure, and reactivity.

A nitrogen-based analogue of the Schrock and Clark "yl-ene-yne" complex, W(CBu t )(CHBu t )(CH2Bu t )(dmpe), has been prepared. The new complex is the nitrido, imido, amido anion [NCr(NPh)(NPri2)2]-, which was structurally characterized with the [K(crypt-2.2.2)]+ counterion. The "Cr-N 1-2-3" complex was prepared from NCr(NHPh)(NPri2)2, which exists as this nitrido-amido tautomer, rather than the bis(imido) Cr(NH)(NPh)(NPri2)2. By selection of electrophile, the nitrido-imido salt K[NCr(NPh)(NPri2)2] can undergo reaction at either the imido or the nitrido to form unusual examples of nitrido or bis(imido) complexes.